Scientific Advisory Board APDA About APDA Scientific Advisory Board Scientific Advisory Board The Board comprises scientists with nationally recognized expertise in a variety of leading edge research areas within the field of Parkinson’s disease. APDA grants are awarded through a competitive application process and reviewed by APDA’s Scientific Advisory Board (SAB). A rigorous review and scoring process of the applications is conducted by the SAB when it convenes annually to review the proposals. In order to be considered for funding, only applications which meet the highest quality are recommended by to the APDA Board of Directors for. Scoring of the grants includes three major areas of criteria including: overall significance and impact in the field of Parkinson’s disease, the appropriateness of the principal investigator and the academic and scientific environment for the proposed project, and the feasibility of the proposed budget and time period for completion. APDA Scientific Advisory Board: (Back row L-R) J. Timothy Greenamyre, MD, PhD, University of Pittsburgh Medical Center; Clemens R. Scherzer, MD, Harvard Medical School and Brigham & Women’s Hospital; Joel S. Perlmutter, MD, Washington University School of Medicine; (Middle Row L-R) Patrick McDermott, Chairman, APDA Board of Directors; Un Jung Kang, MD, Fresco Institute for Parkinson’s and Movement Disorders, New York Langone Health; Vivek K. Unni, MD, PhD, Oregon Health & Science University; David G. Standaert,MD, PhD, Chairman of the APDA SAB, University of Alabama at Birmingham; (Front row L-R); Mary Maral Mouradian, MD, Rutgers Robert Wood Johnson Medical School; Leslie A. Chambers, President & CEO, APDA; Rebecca Gilbert, MD, PhD, VP and Chief Scientific Officer, APDA; Jill L. Ostrem, MD, University of California San Francisco; (Not pictured); Dennis W. Dickson, MD, Mayo Clinic, Jacksonville; Laura Marsh, MD, Michael E. DeBakey VA Medical Center; Evan Yale Snyder, MD, PhD, The Burnham Institute; Marie Hélène Saint-Hilaire, MD, FRCP (C), Boston University School of Medicine SAB Emeritus James Bennett, MD, PhD Marie-Francoise Chesselet, MD, PhD Mahlon DeLong, MD Richard Myers, PhD Jacob Sage, MD Ray Watts, MD G Frederick Wooten Jr., MD David G. Standaert, MD, PhD, Chairman John N. Whitaker Professor and Chair of Neurology University of Alabama at Birmingham, School of Medicine, Birmingham, AL Dennis W. Dickson, MD Professor of Laboratory Medicine & Pathology Mayo Clinic, Jacksonville, FL J. Timothy Greenamyre, MD, PhD Love Family Professor & Vice-Chair of Neurology University of Pittsburgh Medical Center, Pittsburgh, PA Un Jung Kang, MD Founders Professor, Department of Neurology New York Langone Health Fresco Institute for Parkinson’s and Movement Disorders, New York, NY Mary Maral Mouradian, MD William Dow Lovett Professor of Neurology Rutgers Robert Wood Johnson Medical School, Piscataway, NJ Jill Ostrum, MD Professor of Neurology Division Chief, UCSF Movement Disorder and Neuromodulation Center Weill Institute for Neurosciences, University of California San Francisco University of California San Francisco Joel S. Perlmutter, MD Elliot Stein Family Professor of Neurology Professor of Radiology, Neurobiology, Physical Therapy & Occupational Therapy Washington University School of Medicine, St Louis, MO Marie Hélène Saint-Hilaire, MD, FRCP (C) Professor of Neurology Boston University School of Medicine, Boston, MA Clemens R. Scherzer, MD Associate Professor of Neurology Harvard Medical School, Cambridge, MA Evan Yale Snyder, MD, PhD Director, Stem Cell & Regeneration Program The Burnham Institute, La Jolla, CA Vivek K. Unni, MD, PhD Assistant Professor, Oregon Health & Science University Department of Neurology Jungers Center for Neurosciences Research Parkinson Center of Oregon, Portland, OR Daniel Weintraub, MD Professor of Psychiatry and Neurology Department of Neurology Perelman School of Medicine at the University of Pennsylvania
